Position in SABS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$53,624
+$8,006 QoQ
Shares Held
160,189
+1.2% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 86 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names. SABS ranks #373 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in SABS
Export CSV
39 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 SABSW | — | 146,439 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $53,624 | 13,750 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 SABSW | — | 146,439 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $45,618 | 11,911 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 SABSW | — | 146,439 | Shares | Defined | 2026-05-27 | |
| 2025-12-31 | $15,939 | 4,262 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 SABSW | — | 146,439 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $337 | 168 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 SABSW | — | 146,439 | Shares | Defined | 2025-08-15 | |
| 2025-06-30 | $294 | 168 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 SABSW | — | 146,439 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $610 | 449 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 SABSW | — | 146,439 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,272 | 599 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 SABSW | — | 146,439 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $1,886 | 699 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 SABSW | — | 146,439 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,166 | 699 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 SABSW | — | 148,939 | Shares | Defined | 2024-10-17 | |
| 2024-03-31 | $5,442 | 1,199 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 SABSW | — | 148,939 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 | $7,916 | 11,506 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 SABSW | — | 148,939 | Shares | Defined | 2023-11-15 | |
| 2023-09-30 | $9,704 | 15,406 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 SABSW | — | 148,939 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $14,363 | 17,306 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 SABSW | — | 148,939 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $7,614 | 17,306 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 SABSW | — | 148,939 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $10,151 | 17,207 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 SABSW | — | 148,939 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $17,573 | 25,071 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 SABSW | — | 148,939 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $35,889 | 24,752 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 SABSW | — | 150,846 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $93,863 | 24,964 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 SABSW | — | 31,407 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $251,793 | 32,240 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 BCYP | — | 125 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||